Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Rare Disease Day and BIO CEO recaps
Share
Bio.News  •  March 1, 2024
Happy March. We recap yesterday’s Rare Disease Day hearing—and the bipartisan support for a few key BIO priorities—and look at a few things you might have missed at the BIO CEO and Investor Conference. (552 words, 2 minutes, 45 seconds)
Read More

BIO Office Hours: Monetizing the R&D Tax Credit (Day 2)
Share
February 29, 2024
Life science companies generate a significant portion of the annual R&D tax credits claimed every year. Yet, the majority of startups and small-to-midsize businesses do not take advantage of federal, state, and local tax credits. ADP Tax Credit experts will hold 20 minute virtual appointments to answer your questions on the federal tax credit and help determine the likelihood of your company qualifying for the tax credit. What to expect in the overview & 20-minute Zoom session: Federal R&D credit overview and ways to monetize the credit Eligible costs and requirements to qualify Examples of qualifying activities in the Biotech industry State R&D credits R&D project lifecycle
Read More

What to watch on Rare Disease Day
Share
Bio.News  •  February 29, 2024
A leap year means we have an extra day in the month to talk about rare disease patients and R&D. Plus, Agriculture Secretary Tom Vilsack talked about biotech on the Hill and BIO’s David Thomas writes about the vaccine pipeline in International Business Times. (849 words, 4 minutes, 19 seconds)
Read More

BIO Office Hours: Monetizing the R&D Tax Credit (Day 1)
Share
February 28, 2024
Life science companies generate a significant portion of the annual R&D tax credits claimed every year. Yet, the majority of startups and small-to-midsize businesses do not take advantage of federal, state, and local tax credits. ADP Tax Credit experts will hold 20 minute virtual appointments to answer your questions on the federal tax credit and help determine the likelihood of your company qualifying for the tax credit. What to expect in the overview & 20-minute Zoom session: Federal R&D credit overview and ways to monetize the credit Eligible costs and requirements to qualify Examples of qualifying activities in the Biotech industry State R&D credits R&D project lifecycle
Read More

Technology Transfer
Share
Policy

CEOs to Congress: Pass ORPHAN Cures Act
Share
Bio.News  •  February 28, 2024
BIO members and CEOs sent a letter to congressional leaders urging them to pass the ORPHAN Cures Act and support rare disease R&D. Plus, more highlights from the BIO CEO and Investor Conference, including what executives are saying about the policy outlook and AI. (676 words, 3 minutes, 22 seconds)
Read More

BIO CEO & Investor Conference (Day 2)
Share
February 27, 2024
Participate in the BIO CEO & Investor Conference, one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology. Don't miss your opportunity to: Find and request meetings with potential partners using the BIO One-on-One Partnering™ system Discover the latest innovations in biotech during Company Presentations Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities Past speakers include MDs, CSOs and industry analysts discussing the latest information on pipeline innovation along with industry executives and analysts who delve into timely and relevant business models, deal-making, and investment trends. Download the 2023 Program Guide to see the caliber of sessions you can expect at the event.
Read More

I am BIO Podcast (Old)
Share

Is CRISPR the new sickle cell savior?
Share
Bio.News  •  February 27, 2024
On Day 1 of the BIO CEO and Investor Conference, CEOs and experts explained why it’s a great time to invest in innovations such as gene therapy and vaccines. Meanwhile, the I am BIO Podcast launches its new season with a look at the first approved CRISPR-based gene therapy and its impact on sickle cell patients. (780 words, 3 minutes, 54 seconds)
Read More

Biotech Companies Urge Congress to Pass Bipartisan ORPHAN Cures Act
Share
Human Health, Orphan & Rare Diseases  •  Letters, Testimony & Comments  •  February 27, 2024
We are writing to express our strong support for the bipartisan Optimizing Research Progress Hope and New Cures (ORPHAN Cures Act). The legislation, which was introduced by Reps. John Joyce (R-PA) and Wiley Nickel (D-NC) in September,1 corrects a significant flaw in the Inflation Reduction Act (IRA) concerning medicines for rare diseases. Senators Tom Carper (D- DE) and John Barrasso, M.D., (R-WY) introduced the Senate companion to the legislation.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 68
  • 69
  • 70
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO